Pamidronate Disodium Injection Shortage

• • Pamidronate disodium injection, Mylan Institutional (Viatris), 3 mg/mL, 10 mL vial, 1 count, NDC 67457-0430-10
  • Pamidronate disodium injection, Mylan Institutional (Viatris), 9 mg/mL, 10 mL vial, 1 count, NDC 67457-0446-10
  • Pamidronate disodium injection, Pfizer, 3 mg/mL, 10 mL vial, 1 count, NDC 61703-0324-18
  • Pamidronate disodium injection, Pfizer, 6 mg/mL, 10 mL vial, 1 count, NDC 61703-0325-18

• • Areva is not currently marketing pamidronate disodium injection.
  • Pfizer has pamidronate disodium injection on shortage due to manufacturing delays.
  • Viatris did not provide a reason for the shortage.

• • Pamidronate disodium injection, Pfizer, 9 mg/mL, 10 mL vial, 1 count, NDC 61703-0326-18

Estimated Resupply Dates

• • Pfizer has pamidronate disodium 3 mg/mL 10 mL vials and 6 mg/mL 10 mL vials on back order and the company estimates a release date of June 2024 for the 3 mg/mL 10 mL vials and September 2024 for the 6 mg/mL 10 mL vials.
  • Viatris has pamidronate disodium 3 mg/mL 10 mL vials and 9 mg/mL 10 mL vials on back order and the company estimates a release date of early-May 2024.